Interferon's track record: good in hairy-cell leukemia, fair in other hematologic cancers, poor in solid tumors.
D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*
D007372:Interferons